Anbio Biotechnology (NNNN) Retained Earnings (2023 - 2025)

Anbio Biotechnology (NNNN) has 3 years of Retained Earnings data on file, last reported at $23.6 million in Q4 2025.

• On a quarterly basis, Retained Earnings rose 37.29% year-over-year to $23.6 million in Q4 2025; TTM through Dec 2025 was $23.6 million, a 37.29% increase from a year earlier, with the FY2025 full-year figure at $23.6 million, up 37.29% from the prior year.
• Retained Earnings for Q4 2025 stood at $23.6 million, down from $6563.6 billion in the prior quarter.
• Over the last five years, Retained Earnings for NNNN reached as high as $6563.6 billion in Q2 2025 and fell as low as $14.8 million in Q4 2023.
• Historically, Retained Earnings has averaged $1640.9 billion across 3 years, with a median of $20.4 million in 2024.
• Across the five-year window, Retained Earnings increased 16.03% in 2024 and jumped 37.29% in 2025, its largest moves.
• Year by year, Retained Earnings stood at $14.8 million in 2023, then advanced by 16.03% to $17.2 million in 2024, then jumped by 37.29% to $23.6 million in 2025.
• Per Business Quant data, the three most recent Retained Earnings figures were $23.6 million in Q4 2025, $6563.6 billion in Q2 2025, and $17.2 million in Q4 2024.